Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
24.90
-0.90 (-3.49%)
Aug 3, 2026, 5:24 PM IDT

TLV:CBI Financials Overview

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.10.370.22
Revenue Growth
----71.89%65.18%8.74%
Gross Profit
---0.10.370.22
Operating Income
-4.72-4.72-6.63-10.18-12.51-12.65
Net Income
-13.32-13.32-62.46-31.05-61.74-89.58
Earnings Per Share
-0.09-0.09-0.40-0.20-0.39-0.57
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.691.695.0113.3612.8953.05
Total Debt
17.7617.7620.8435.7636.7353.78
Net Cash (Debt)
-16.07-16.07-15.83-22.4-23.85-0.73
Net Cash Growth
------
Net Cash Per Share
-0.10-0.10-0.10-0.14-0.15-0.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.95-3.95-6.48-8.51-59.04-41.33
Capital Expenditures
----0.01-1.27-1.59
Free Cash Flow
-3.95-3.95-6.48-8.52-60.31-42.92
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----9789.42%-3380.00%-5645.09%
Pretax Margin
----27012.50%-11087.30%-29726.34%
Profit Margin
----29856.73%-16686.49%-39992.41%
FCF Margin
----8190.39%-16300.00%-19160.71%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---598.73266.21827.64